(ℹ) Join us now at the IRC channel | ䷉ Find the plain text version at this address (HTTP) or in Gemini (how to use Gemini) with a full GemText version.
*You are now known as schestowitz | Sep 09 00:08 | |
schestowitz | http://ipkitten.blogspot.com/2023/08/make-no-bones-about-it-credibility-test.html?showComment=1694103240953#c6519183139123958630 | Sep 09 00:54 |
---|---|---|
schestowitz | "Kant, you make an excellent point, but I remind you of T2003/08, which 'stretched' a Swiss-style medical use claim to cover use of particular column to treat a patient’s plasma outside the body. See the relevant claim below:<br /><br /> ‘1. Use of a specific ligand for human immunoglobulin in the manufacture of a column having said ligand coupled thereto for the treatment of a patient suffering from dilated cardiomyopathy, said tre | Sep 09 00:54 |
schestowitz | atment comprising passing plasma of the patient over the column under conditions which effect the binding of said specific ligand to immunoglobulin in the patient's plasma, thereby removing a significant portion of the immunoglobulin from the patient's plasma, and reinfusing the plasma to the patient.’ <br /><br />[Also discussed in old IPKat article here https://ipkitten.blogspot.com/2014/05/swiss-type-claims-and-double-patenting.htm | Sep 09 00:54 |
schestowitz | l]<br /><br />So my belief is that the substance does not need to provide the therapeutic effect. Only the medical method as a whole needs to do that as recited in the claim. I believe T1020/03 established that ANY method of treatment can be expressed as an allowable medical use claim if a substance is somehow involved. The in vivo diagnostics case law for contrast agents for use in MRI also supports this approach with the invention oft | Sep 09 00:54 |
schestowitz | en being in the MRI method, and not in a new contrast agent." | Sep 09 00:54 |
-TechBytesBot/#techbytes-ipkitten.blogspot.com | Make no bones about it: The "credibility test" has no place in the novelty assessment of second medical use claims (T 0558/20) - The IPKat | Sep 09 00:54 | |
-TechBytesBot/#techbytes- ( status 404 @ https://ipkitten.blogspot.com/2014/05/swiss-type-claims-and-double-patenting.htm ) | Sep 09 00:54 | |
schestowitz | "The adaptation of the description is not the subject of this post and I agree there is no reason to discuss this issue now. I am only surprised that you call it an old story since a referral to the EBA is suggested by the Board of case T 56/21. If it happens, the issue will be a very hot topic again and there will be ample opportunity for debates.<br /><br />From the Board’s communication of June suggesting the referral, I take this | Sep 09 00:55 |
schestowitz | robust policy statement : « It is not for the Office to harmonise the extent of protection conferred by European patents (and applications) by bringing the description and/or the drawings the amended claims held allowable. » (Reason 3.2.3)." | Sep 09 00:55 |
schestowitz | "Mr. Thomas, for your reference, CIPA and CNIPA are not the same body. CNIPA was the "Committee of National Institutes of Patent Agents", a loose association of European patent bar associations, such as CIPA, PAK etc." | Sep 09 00:55 |
*jacobk has quit (Ping timeout: 2m30s) | Sep 09 01:46 | |
*jacobk (~quassel@8cgmbeq9ipg9s.irc) has joined #techbytes | Sep 09 03:15 | |
*MinceR gives voice to jacobk | Sep 09 03:18 | |
*jacobk has quit (Ping timeout: 2m30s) | Sep 09 05:24 | |
*jacobk (~quassel@8cgmbeq9ipg9s.irc) has joined #techbytes | Sep 09 05:31 | |
*jacobk has quit (Ping timeout: 2m30s) | Sep 09 06:27 | |
*jacobk (~quassel@32hz32it3ih2k.irc) has joined #techbytes | Sep 09 07:25 | |
*u-amarsh04 has quit (Quit: Konversation terminated!) | Sep 09 09:38 | |
*u-amarsh04 (~amarsh04@tqmhqqifyxsti.irc) has joined #techbytes | Sep 09 09:42 | |
*MinceR gives voice to u-amarsh04 jacobk | Sep 09 13:14 | |
*jacobk has quit (Ping timeout: 2m30s) | Sep 09 13:18 | |
*XFaCE has quit (Quit: Retiring completely for now ("Automatic for the people, thanks for all the fish")) | Sep 09 22:13 | |
*Noisytoot has quit (Quit: ZNC 1.8.2 - https://znc.in) | Sep 09 22:14 | |
*XFaCE (~XFaCE@uzfeivw9fp6ba.irc) has joined #techbytes | Sep 09 22:15 | |
*Noisytoot (~noisytoot@tkbibjhmbkvb8.irc) has joined #techbytes | Sep 09 22:16 | |
*MinceR gives voice to XFaCE Noisytoot | Sep 09 22:16 | |
*liberty_box has quit (Quit: Leaving) | Sep 09 22:20 |
Generated by irclog2html.py
2.6 | ䷉ find the plain text version at this address (HTTP) or in Gemini (how to use Gemini) with a full GemText version.